Mortality and Cardiovascular Events in Patients With Chronic Kidney Disease and Sleep Apnea Syndrome.

ABSTRACT:

Background

The incidence of sleep apnea syndrome (SAS) is reported to be markedly high in patients with chronic kidney disease (CKD). Therefore, it is extremely important to know whether SAS affects prognosis in patients with CKD. Further, it is imperative to understand the prognostic impact of home continuous positive airway pressure (CPAP) therapy, which is one of the most common treatments for SAS.

Materials and methods

We used a clinical database to identify patients with CKD using diagnosis codes. We included patients with CKD aged 20 years or more, not on renal replacement therapy, with a known change in renal function for at least 1 year. The propensity score was used to compare event rates for patients with SAS and those without SAS. In addition, the prognostic impac

SUBMITTER: Watanabe Y 

PROVIDER: S-EPMC9192968 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature